Effect of immune checkpoint inhibitor time-of-day infusion on survival in advanced biliary tract cancer: a propensity score-matched analysis
Timing of ICI administration affects efficacy in advanced BTC, with pre-16:30 infusions linked to better survival. Larger, prospective studies are needed to validate these results.
Authors
- Jiamin Guo
- Lingqi Sun (ORCID: https://orcid.org/0000-0002-9650-1285)
- Yichen Zheng (ORCID: https://orcid.org/0000-0001-7998-0272)
- Fang Shi (ORCID: https://orcid.org/0009-0006-5121-6831)
- Ji Ma (ORCID: https://orcid.org/0000-0003-4486-2641)
- Tianhui Ren (ORCID: https://orcid.org/0000-0003-4369-9678)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fimmu.2024.1512972
- Citations
- 3
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- Sichuan University
- West China Hospital, Sichuan University
- Key Research and Development Program of Sichuan Province